日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

C-C motif chemokine receptor-like 2 promotes the interferon-γ signaling response in myeloid neoplasms with erythroid differentiation and mutated TP53.

CC 基序趋化因子受体样 2 促进具有红系分化和 TP53 突变的髓系肿瘤中的干扰素-γ 信号反应。

Naji Nour Sabiha, Pasca Sergiu, Chatzilygeroudi Theodora, Toledano-Sanz Pablo, Rimando Joseph, An Yuju, Hemani Yashvi, Perkins Brandy, Zeng Xinghan, Talbot Conover Jr, Paun Bogdan, Abdulmalik Abdulmuez, Lossos Chen, Boronina Tatianna R, Sinanidis Ilias, Tsakiroglou Panagiotis, Fernandes Priyanka, Esteb Christopher, Ambinder Alexander J, Cole Robert N, Xian Rena, Gojo Ivana, Paul Suman, Levis Mark J, DeZern Amy E, Luznik Leo, Karanika Styliani, Resar Linda S, Jones Richard J, Bunz Frederick, Gondek Lukasz, Arvanitis Marios, Karantanos Theodoros

Improved outcomes of acute lymphoblastic leukemia after allogeneic blood or marrow transplantation with highdose post-transplantation cyclophosphamide in the era of more effective pre-transplant therapy

在移植前治疗效果日益显著的时代,采用高剂量移植后环磷酰胺治疗异基因造血干细胞移植或骨髓移植可改善急性淋巴细胞白血病患者的预后。

Webster, Jonathan A; Reed, Madison; Tsai, Hua-Ling; Imus, Philip H; Smith, Douglas B; Ambinder, Alexander J; Levis, Mark J; DeZern, Amy E; Prince, Gabrielle T; Jain, Tania; Bolaños-Meade, Javier; Gondek, Lukasz P; Ghiaur, Gabriel; Dalton, William Brian; Karantanos, Theodoros; Paul, Suman; Fuchs, Ephraim J; Sterling, Cole; Swinnen, Lode J; Wagner-Johnston, Nina; Ambinder, Richard F; Gocke, Christian B; Ali, Syed Abbas; Huff, Carol Ann; Luznik, Leo; Varadhan, Ravi; Jones, Richard J; Gojo, Ivana

Younger haplo-donors improve older patient survival outcomes

年轻的单倍体供者能够改善老年患者的生存结果。

Ghorab, Ahmad; Luznik, Leo

CCRL2 promotes the interferon-γ signaling response in myeloid neoplasms with erythroid differentiation and mutated TP53

CCRL2促进具有红系分化和TP53突变的髓系肿瘤中的干扰素-γ信号反应

Naji, Nour Sabiha; Pasca, Sergiu; Chatzilygeroudi, Theodora; Toledano-Sanz, Pablo; Rimando, Joseph; Hemani, Yashvi; Perkins, Brandy; Zeng, Xinghan; Talbot, Conover; Paun, Bogdan; Abdulmalik, Abdulmuez; Lossos, Chen; Boronina, Tatianna R; Sinanidis, Ilias; Tsakiroglou, Panagiotis; Fernandes, Priyanka; Esteb, Christopher; Ambinder, Alexander J; Cole, Robert N; Xian, Rena; Gojo, Ivana; Paul, Suman; Levis, Mark J; DeZern, Amy E; Luznik, Leo; Karanika, Styliani; Resar, Linda S; Jones, Richard J; Bunz, Frederick; Gondek, Lukasz; Arvanitis, Marios; Karantanos, Theodoros

Relapse after allogeneic transplantation with post-transplant cyclophosphamide: Shattering myths and evolving insight

异基因移植后环磷酰胺治疗复发:打破迷思与新认识

McCurdy, Shannon R; Luznik, Leo

Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-Sponsored Prospective Clinical Trial

使用移植后环磷酰胺治疗不匹配无关供者骨髓移植患者的三年预后:一项由国家骨髓捐献者计划赞助的前瞻性临床试验的随访结果

Shaw, Bronwen E; Jimenez-Jimenez, Antonio Martin; Burns, Linda J; Logan, Brent R; Khimani, Farhad; Shaffer, Brian C; Shah, Nirav N; Mussetter, Alisha; Tang, Xiao-Ying; McCarty, John M; Alavi, Asif; Farhadfar, Nosha; Jamieson, Katarzyna; Hardy, Nancy M; Choe, Hannah; Ambinder, Richard F; Anasetti, Claudio; Perales, Miguel-Angel; Spellman, Stephen R; Howard, Alan; Komanduri, Krishna V; Luznik, Leo; Norkin, Maxim; Pidala, Joseph A; Ratanatharathorn, Voravit; Confer, Dennis L; Devine, Steven M; Horowitz, Mary M; Bolaños-Meade, Javier

Allogeneic Blood or Marrow Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Acute Lymphoblastic Leukemia in Patients Age ≥55 Years

异基因造血干细胞移植联合大剂量移植后环磷酰胺治疗年龄≥55岁的急性淋巴细胞白血病

Webster, Jonathan A; Reed, Madison; Tsai, Hua-Ling; Ambinder, Alexander; Jain, Tania; Dezern, Amy E; Levis, Mark J; Showel, Margaret M; Prince, Gabrielle T; Hourigan, Christopher S; Gladstone, Douglas E; Bolanos-Meade, Javier; Gondek, Lukasz P; Ghiaur, Gabriel; Dalton, W Brian; Paul, Suman; Fuchs, Ephraim J; Gocke, Christian B; Ali, Syed Abbas; Huff, Carol Ann; Borrello, Ivan M; Swinnen, Lode; Wagner-Johnston, Nina; Ambinder, Richard F; Luznik, Leo; Gojo, Ivana; Smith, B Douglas; Varadhan, Ravi; Jones, Richard J; Imus, Philip H

Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide for Peripheral T Cell Lymphoma: The Importance of Graft Source

异基因血液或骨髓移植联合移植后环磷酰胺治疗外周T细胞淋巴瘤:移植来源的重要性

Sterling, Cole H; Hughes, Michael S; Tsai, Hua-Ling; Yarkony, Kathryn; Fuchs, Ephraim J; Swinnen, Lode J; Paul, Suman; Bolaños-Meade, Javier; Luznik, Leo; Imus, Philip H; Ali, Syed Abbas; Jain, Tania; Ambinder, Alexander; DeZern, Amy; Huff, Carol Ann; Gocke, Christian B; Varadhan, Ravi; Wagner-Johnston, Nina; Jones, Richard J; Ambinder, Richard F

Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learning

免疫分析和机器学习揭示移植后环磷酰胺治疗后GVHD和复发的特征

McCurdy, Shannon R; Radojcic, Vedran; Tsai, Hua-Ling; Vulic, Ante; Thompson, Elizabeth; Ivcevic, Sanja; Kanakry, Christopher G; Powell, Jonathan D; Lohman, Brian; Adom, Djamilatou; Paczesny, Sophie; Cooke, Kenneth R; Jones, Richard J; Varadhan, Ravi; Symons, Heather J; Luznik, Leo

Immune dysfunction signatures predict outcomes and define checkpoint blockade-unresponsive microenvironments in acute myeloid leukemia

免疫功能障碍特征可预测急性髓系白血病的预后并定义对检查点阻断无反应的微环境。

Rutella, Sergio; Vadakekolathu, Jayakumar; Mazziotta, Francesco; Reeder, Stephen; Yau, Tung-On; Mukhopadhyay, Rupkatha; Dickins, Benjamin; Altmann, Heidi; Kramer, Michael; Knaus, Hanna A; Blazar, Bruce R; Radojcic, Vedran; Zeidner, Joshua F; Arruda, Andrea; Wang, Bofei; Abbas, Hussein A; Minden, Mark D; Tasian, Sarah K; Bornhäuser, Martin; Gojo, Ivana; Luznik, Leo